Prevalence of oral human papillomavirus by vaccination status among young adults (18–30 years old) |
| |
| Institution: | 1. Center for Interdisciplinary Research in Women’s Health, Department of Obstetrics & Gynecology, University of Texas Medical Branch, United States;1. Center for Interdisciplinary Research in Women’s Health, Department of Obstetrics & Gynecology, University of Texas Medical Branch, United States;2. Center for Interdisciplinary Research in Women’s Health, University of Texas Medical Branch, United States;3. Department of Otolaryngology, University of Texas Medical Branch, United States;1. Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia;2. Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia;3. Murdoch Childrens Research Institute, Parkville, VIC, Australia;4. Department of Microbiology and Infectious Diseases, The Royal Women''s Hospital, Parkville, VIC, Australia;5. Department of Obstetrics Gynaecology, University of Melbourne, Parkville, VIC, Australia;1. Charles University in Prague—2nd Faculty of Medicine, V Úvalu 84, 150 06 Prague 5, Czech Republic;2. Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague 4, Czech Republic;1. Molecular Biology Laboratory, Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil;2. Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;3. Infections and Cancer Biology Group, International Agency for Cancer Research (IARC), Lyon, France;4. Ludwig Institute for Cancer Research, São Paulo branch, São Paulo, Brazil;5. Centro de Referência e Treinamento DST/Aids, São Paulo, Brazil;6. Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Mexico;7. Department of Radiology and Oncology, School of Medicine, University of São Paulo, São Paulo, Brazil;1. Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil;2. Head and Neck Surgery Department, AC Camargo Cancer Center and Department of Head and Neck Surgery, University of Sao Paulo Medical School, São Paulo, Brazil;3. Centro Oncológico BP, Beneficência Portuguesa de São Paulo, Brazil;4. Department of Clinical Oncology, São Paulo State Cancer Institute (ICESP-FMUSP), São Paulo, Brazil;5. DOM Oncology Group, Divinópolis, Brazil;6. UNESCO Chair of Bioethics, Brasília University, Brasília, DF, Brazil;7. Medical Oncology Department, AC Camargo Cancer Center, São Paulo, SP, Brazil;8. Dental Oncology Service, São Paulo State Cancer Institute (ICESP-FMUSP), São Paulo, Brazil;9. Oral Medicine Department, Hospital Sírio-Libanês, São Paulo, Brazil;1. University of Strathclyde, Glasgow, UK;2. Health Protection Scotland, Glasgow, UK;3. University of Edinburgh, Edinburgh, UK;4. International Prevention Research Institute, Lyon, France;5. Scottish Human Papillomavirus Reference Laboratory, Royal Infirmary of Edinburgh, UK;6. Department of Pathology, University of Edinburgh, UK;7. University of Aberdeen, Aberdeen, UK |
| |
| Abstract: | BackgroundAlthough there is evidence that human papillomavirus (HPV) vaccination may protect against oral HPV infection, no current research has demonstrated this in the general population.MethodsWe used repeated cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) between 2009 and 2014. Participants 18–30 years who indicated whether they had received the HPV vaccine and provided an adequate oral sample were included (N = 3040). Oral HPV types were grouped by vaccine-type (types 6, 11, 16, 18) and by risk (high or low risk). Chi-square analyses compared oral HPV prevalence by vaccination status.ResultsVaccinated adults had a lower prevalence of vaccine-type oral HPV (types 6, 11, 16, 18) compared to unvaccinated adults. Prevalence of non-vaccine high-risk oral HPV was similar between HPV vaccinated and unvaccinated participants.ConclusionsHPV vaccination appears to provide protection against vaccine-type oral HPV infection among males and females in the general population. |
| |
| Keywords: | Oral cancer HPV vaccination Primary oral cancer prevention Oral HPV infection |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
